Haleon's Advil "stands out for its commitment to Black pain inequity via its 'Pain Equity Project' initiative," according to ...

GSK spun off Haleon to form a new consumer healthcare entity, driven by activist investor pressure and its underperforming share price. Haleon’s financials show steady growth with 2023 revenues ...

Haleon's share price increased by 20% since July, mainly driven by strong H1 2024 results and strategic moves, among them, increasing their stake in Tianjin TSKF Pharmaceutical. The upcoming ...

(Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil ...

Pfizer will receive around 2.66 billion pounds ($3.56 billion) in aggregate from Haleon from an offering and a share buyback. Goldman Sachs International said Tuesday that the pharmaceutical ...

(RTTNews) - Pfizer said, further to the Launch Announcement on 30 September 2024, it has sold 640 million ordinary shares in Haleon plc, at a price of 380 pence per share, raising gross sale ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pfizer said it intends to sell around 540 million ordinary shares in British consumer-healthcare business Haleon, or about 5.9% of the company's issued share capital. The pharmaceutical giant said ...

Dealscategory Odyssey in advanced talks to buy Honeywell's face mask unit, Bloomberg News reports 5:34 PM UTC Dealscategory Tetragon in talks over possible sale of Equitix, sources say 5:10 PM UTC ...

Placing at a 3.3% discount to Haleon's last close Haleon to buy back 230 mln stg worth of shares from Pfizer Pfizer to remain top Haleon shareholder -LSEG data Shares in Haleon, which was created ...